Ganoderic Acid A Mitigates Inflammatory Bowel Disease through Modulation of AhR Activity by Microbial Tryptophan Metabolism-Reference-Cited by-同舟云学术

Ganoderic Acid A Mitigates Inflammatory Bowel Disease through Modulation of AhR Activity by Microbial Tryptophan Metabolism

Published:2024-07-30 Issue:32 Volume:72 Page:17912-17923
ISSN:0021-8561
Container-title:Journal of Agricultural and Food Chemistry
language:en
Short-container-title:J. Agric. Food Chem.

Author:

Kou Rong-Wei¹^ORCID,Li Zhi-Qing²,Wang Jia-Lin²,Jiang Shi-Qi²,Zhang Rui-Jing²,He Yang-Qing¹^ORCID,Xia Bing²,Gao Jin-Ming³^ORCID

Affiliation:

1. School of Science, Xi’an University of Technology, Xi’an 710048, Shaanxi, People’s Republic of China

2. College of Food Science and Engineering, Northwest A&F University, Yangling 712100, Shaanxi, People’s Republic of China

3. Shaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, Yangling 712100, Shaanxi, People’s Republic of China

Funder

Xi'an University of Technology

Natural Science Basic Research Program of Shaanxi Province

National Natural Science Foundation of China

Shaanxi Fundamental Science Research Project for Chemistry and Biology

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jafc.4c01166

Reference59 articles.

1. Neutrophils: from IBD to the gut microbiota

2. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

3. Therapeutic Opportunities in Inflammatory Bowel Disease: Mechanistic Dissection of Host-Microbiome Relationships

4. The microbiome in inflammatory bowel diseases: from pathogenesis to therapy

5. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease